|
Murcia L, Carrilero B, Albajar Viñas P, Segovia M. Nifurtimox chemotherapy: collateral effects in treated Trypanosoma cruzi infected patients. Rev Esp Quimioter. 2012 Mar;25(1):74-5. PubMed PMID: 22488545.
AÑO: 2012; IF: 0.836
|
22488545
|
Murcia L, Carrilero B, Segovia M. Limitations of currently available Chagas disease chemotherapy. Rev Esp Quimioter. 2012 Mar;25(1):1-3. PubMed PMID: 22488534.
AÑO: 2012; IF: 0.836
|
|
Iborra-Bendicho MA, Albert-Hernández M, Márquez-Contreras C, Segovia-Hernández M. [ARCHITECT Chagas(®): a new diagnostic tool in Chagas disease]. Enferm Infecc Microbiol Clin. 2012 Oct;30(8):463-5. doi: 10.1016/j.eimc.2012.02.002. Epub 2012 Mar 23. Spanish. PubMed PMID: 22446008.
AÑO: 2012; IF: 1.478
|
|
Iborra MA, García E, Carrilero B, Segovia M. [Malaria diagnosis and treatment: analysis of a cohort of hospitalised patients at a tertiary level hospital (1998-2010)]. Rev Esp Quimioter. 2013 Mar;26(1):6-11. Spanish. PubMed PMID: 23546456.
AÑO: 2013; IF: 0.905
|
|
Murcia L, Carrilero B, Saura D, Iborra MA, Segovia M. [Diagnosis and treatment of Chagas disease]. Enferm Infecc Microbiol Clin. 2013 Feb;31 Suppl 1:26-34. doi: 10.1016/S0213-005X(13)70111-3. Spanish. PubMed PMID: 23453228.
AÑO: 2013; IF: 1.881
|